Quantum chemical modeling of the inhibition mechanism of monoamine oxidase by oxazolidinone and analogous heterocyclic compounds

References

• Lu X, Rodrigues M, Gu W, Silverman RB. Inactivation of mitochondrial monoamine oxidase B by methylthio-substituted benzylamines. Bioorg Med Chem 2003;11:4423–30
   PubMed Web of Science ®Google Scholar
• Ives JL, Heym J. Antidepressant agents. Annu Rep Med Chem 1989;24:21–9
   Web of Science ®Google Scholar
• Tetrud VW, Langston JW. The effect of deprenyl (selegiline) on the natural history of Parkinson’s disease. Science 1989;245:519–22
   PubMed Web of Science ®Google Scholar
• Silverman RB. Radical ideas about monoamine-oxidase. Acc Chem Res 1995;28:335–42, and the references therein
   Web of Science ®Google Scholar
• Haefely WE, Burkard WP, Cesura AM, et al. Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology 1992;106:6–14
   Web of Science ®Google Scholar
• Cesura AM, Fletcher A. The new generation of monoamine oxidase inhibitors. Prog Drug Res 1992;38:171–297
   PubMedGoogle Scholar
• Binda C, Newton-Vinson P, Hubalek F, et al. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol 2002;9:22–6
   PubMedGoogle Scholar
• Scrutton NS. Chemical aspects of amine oxidation by flavoprotein enzymes. Nat Prod Rep 2004;21:722–30
   PubMedGoogle Scholar
• Edmondson DE, Mattevi A, Binda C, Hubalek F. Structure and mechanism of monoamine oxidase. Curr Med Chem 2004;11:1983–93
   PubMed Web of Science ®Google Scholar
• Fitzpatrick PF. Oxidation of amines by flavoproteins. Arch Biochem Biophys 2010;493:13–25
   PubMed Web of Science ®Google Scholar
• Dunn RV, Munro AW, Turner NJ, et al. Tyrosyl radical formation and propagation in flavin dependent monoamine oxidases. Chem BioChem 2010;11:1228–31
   Google Scholar
• Erdem SS, Karahan Ö, Yıldız İ, Yelekçi K. A computational study on the amine-oxidation mechanism of monoamine oxidase: insight into the polar nucleophilic mechanism. Org Biomol Chem 2006;4:646–8
   PubMedGoogle Scholar
• Akyüz MA, Erdem SS, Edmondson DE. The aromatic cage in the active site of monoamine oxidase B: effect on the structural and electronic properties of bound benzylamine and p-nitrobenzylamine. J Neural Trans 2007;114:693–8
   PubMed Web of Science ®Google Scholar
• Erdem SS, Büyükmenekşe B. Computational investigation on the structure–activity relationship of the biradical mechanism for monoamine oxidase. J Neural Trans 2011;118:1021–9
   PubMedGoogle Scholar
• Miller JR, Edmondson DE. Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A. Biochemistry 1999;38:13670–83
   PubMedGoogle Scholar
• Silverman RB, Cesarone JM, Lu X. Stereoselective ring-opening of 1-phenylcyclopropylamine catalyzed by monoamine oxidase-b. J Am Chem Soc 1993;115:4955–61
   Google Scholar
• Silverman RB, Zelechonok Y. Evidence for a hydrogen-atom transfer mechanism or a proton fast electron-transfer mechanism for monoamine-oxidase. J Org Chem 1992;57:6373–4
   Google Scholar
• Silverman RB, Lu X, Zhou JJP, Swihart A. Monoamine-oxidase b-catalyzed oxidation of cinnamylamine 2,3-oxide – further evidence against a nucleophilic mechanism. J Am Chem Soc 1994;116:11590–1
   Google Scholar
• Silverman RB, Ding CZ, Borillo JL, Chang JT. Mechanism-based enzyme inactivation via a deactivated cyclopropane intermediate. J Am Chem Soc 1993;115:2982–3
   Google Scholar
• Wang X, Silverman RB. 2-(Iodoethenyl)benzyl amines as potential probes for radical intermediates formed during monoamine oxidase-catalyzed oxidations. J Org Chem 1998;63:7357–63
   PubMedGoogle Scholar
• Silverman RB, Zhou JP, Eaton PE. Inactivation of monoamine-oxidase by (aminomethyl)cubane – 1st evidence for an alpha-amino radical during enzyme catalysis. J Am Chem Soc 1993;115:8841–2
   Google Scholar
• Silverman RB. Electron transfer chemistry of monoamine oxidase. In: Mariano PS, ed. Advances in electron transfer chemistry. Greenwich: JAI Press; 1992:177–213
   Google Scholar
• Silverman RB, Hiebert CK. Inactivation of monoamine oxidase-a by the monoamine oxidase-b inactivators 1-phenylcyclopropylamine, 1-benzylcyclopropylamine, and n-cyclopropyl-alpha-methylbenzylamine. Biochemistry 1988;27:8448–53
   PubMed Web of Science ®Google Scholar
• Zhong BY, Silverman RB. Identification of the active site cysteine in bovine liver monoamine oxidase B. J Am Chem Soc 1997;119:6690–1
   Web of Science ®Google Scholar
• Binda C, Hubalek F, Li M, et al. Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane. FEBS Lett 2004;564:225–8
   PubMed Web of Science ®Google Scholar
• de Colibus L, Binda C, Lustig A, et al. Three-dimensional structure of human monoamine oxidase A (MAO-A): relation to the structures of rat MAO-A and human MAO-B. Proc Natl Acad Sci 2005;102:12684–9
   PubMed Web of Science ®Google Scholar
• Son SY, Ma J, Kondou Y, et al. Structure of human monoamine oxidase A at 2.2-Å resolution: the control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci 2008;105:5739–44
   PubMed Web of Science ®Google Scholar
• Ma J, Yoshimura M, Yamashita E, et al. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J Mol Biol 2004;338:103–14
   PubMedGoogle Scholar
• Lu X, Rodriguez M, Ji H, et al. Irreversible inactivation of mitochondrial monoamine oxidases. In: Chapman SK, Perham RN, Scrutton NS, eds. Flavins and flavoproteins. Proceedings of the 14th International Symposium; 2002 Jul 14–18; Cambridge. Berlin: Rudolf Weber; 2002:817–30
   Google Scholar
• Vintém APB, Price NT, Silverman RB, Ramsay RR. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines. Bioorg Med Chem 2005;13:3487–95
   PubMedGoogle Scholar
• Lu X, Rodriguez M, Gu W, Silverman RB. Inactivation of mitochondrial monoamine oxidase B by methylthio-substituted benzylamines. Bioorg Med Chem 2003;11:4423–30
   PubMed Web of Science ®Google Scholar
• Erdem SS, Yelekci K. Computer modeling of oxygen containing heptylamines as monoamine oxidase inactivators. J Mol Struct (Theochem) 2001;572:97–106
   Google Scholar
• Borstnar R, Repic M, Krzan M, et al. Irreversible inhibition of monoamine oxidase B by the antiparkinsonian medicines rasagiline and selegiline: a computational study. Eur J Org Chem 2011;2011:6419–33
   Google Scholar
• Silverman RB, Ding CZ. Chemical-model for a mechanism of inactivation of monoamine-oxidase by heterocyclic-compounds – electronic effects on acetal hydrolysis. J Am Chem Soc 1993;115:4571–6
   Google Scholar
• Ding CZ, Silverman RB. Transformation of heterocyclic reversible monoamine oxidase-b inactivators into irreversible inactivators by N-methylation. J Med Chem 1993;36:3606–10
   PubMedGoogle Scholar
• Ding CZ, Silverman RB. 4-(Aminomethyl)-1-aryl-2-pyrrolidinones, a new class of monoamine oxidase-b inactivators. J Enzyme Inhib 1992;6:223–31
   PubMed Web of Science ®Google Scholar
• Ding CZ, Silverman RB. Selective inactivation of monoamine-oxidase-b by aminoethyl 3-chlorobenzyl ether. Bioorg Med Chem Lett 1993;3:2077–8
   Web of Science ®Google Scholar
• Lu XL, Silverman RB. Monoamine oxidase B-catalyzed reactions of cis- and trans-5-aminomethyl-3-(4-methoxyphenyl)dihydrofuran-2(3H)-ones. Evidence for a reversible redox reaction. J Am Chem Soc 1998;120:10583–7
   Google Scholar
• Ding CZ, Silverman RB. 5-(Aminomethyl)-3-aryldihydrofuran-2(3H)-ones, a new class of monoamine oxidase-B inactivators. J Med Chem 1992;35:885–9
   PubMed Web of Science ®Google Scholar
• Silverman RB, Ding CZ, Gates KS. Design and mechanism of monoamine oxidase inactivators from a chemical perspective. In: Testa B, Kyburz E, Fuhrer W, Giger R, eds. Perspectives in medicinal chemistry. Basel: Verlag Helvetica Chimica Acta; 1993:73
   Google Scholar
• Jones TZE, Fleming P, Eyermann CJ, et al. Orientation of oxazolidinones in the active site of monoamine oxidase. Biochem Pharmacol 2005;70:407–16
   PubMedGoogle Scholar
• Spartan 04, Wavefunction Inc., Irvine, CA, USA. Available from: http://www.wavefun.com
   Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 03 revision D.01. Wallingford, CT: Gaussian Inc.; 2004
   Google Scholar
• Gonzalez C, Schlegel HB. An improved algorithm for reaction-path following. J Chem Phys 1989;90:2154–62
   Web of Science ®Google Scholar
• Chambers CC, Hawkins GD, Cramer CJ, Truhlar DG. A model for aqueous solvation based on class IV atomic charges and first-solvation-shell effects. J Phys Chem B 1996;100:16385–98
   Web of Science ®Google Scholar
• Steinfield JI, Francisco JS, Hase WL. Chemical kinetics and dynamics. Upper Saddle River (NJ): Prentice Hall; 1989:321–3
   Google Scholar
• Li M, Binda C, Mattevi A, Edmondson DE. Functional role of the “Aromatic Cage” in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins. Biochemistry 2006;45:4775–84
   PubMedGoogle Scholar